The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•12 April 2026•

1 min read

Wealth Management Firms Execute Strategic Rebalancing in US Equity Portfolios

FDA and Novo Nordisk logos above a laboratory scene with computer monitors, chemical structures, medicine bottles, and pills.

Key Facts

1Greenup Street Wealth Management reduced its stake in Lam Research by 92% and in Air Products and Chemicals by 57.1%.

2Bartlett & CO. Wealth Management increased its holdings in Texas Pacific Land by 200% and in PACCAR by 76.6%.

3Ritholtz Wealth Management raised its stake in PepsiCo by 33.1% following the company's announcement of a $10 billion share repurchase plan.

Version History

1 additional source confirmed this story

Several wealth management firms have disclosed significant adjustments to their stock portfolios during the fourth quarter, involving both substantial liquidations and aggressive new acquisitions across various sectors. Greenup Street Wealth Management notably reduced its stake in Lam Research by 92% and in Air Products and Chemicals by 57.1%. Conversely, Bartlett & CO. Wealth Management significantly increased its holdings, boosting its stake in Texas Pacific Land by 200% and in PACCAR by 76.6%. Ritholtz Wealth Management also raised its position in PepsiCo by 33.1% following the company's announcement of a $10 billion share repurchase plan. These adjustments were primarily driven by quarterly earnings results and institutional rebalancing strategies. The moves highlight how institutional investors are reacting to corporate actions and shifting market dynamics to optimize their equity exposure.